Easing the current burden on glaucoma services

Phil Lai, MD, chief medical officer of Perfuse Therapeutics, said the company's goal is to pioneer disease-modifying treatment that targets an underlying pathology of ischemia

The framework covers ocular hypertension to severe progression

Laser surgery is an appropriate adjunctive therapy across the continuum of glaucoma care, as well as a safe option for patients who also have cataracts and other complicating factors

Vitamins B6, B9 and B12 were found to be neuroprotective against retinal ganglion cell death

Social determinants of health challenge our existing expectations

The novel nitric oxide-donating bimatoprost eye drop is designed to lower IOP in patients with open-angle glaucoma or ocular hypertension